What is Biogenetics?
BioGenetics Corporation is a specialized provider of cryobanking and fertility laboratory services. The company offers comprehensive donor screening and advanced cryopreservation techniques for reproductive cells and tissues, including sperm, embryos, and ovarian tissue. Biogenetics facilitates various donor programs, such as Anonymous, Access, and Total Access ID (T.A.ID), and ensures global distribution of sperm from diverse ethnic backgrounds. Their service portfolio also extends to urology and laboratory diagnostics focused on male fertility evaluation, catering to both prospective donors and recipients and ensuring the secure transport and long-term storage of vital reproductive materials.
How much funding has Biogenetics raised?
Biogenetics has raised a total of $72K across 1 funding round:
Debt
$72K
Debt (2021): $72K with participation from PPP
Key Investors in Biogenetics
PPP
Public-Private Partnership
What's next for Biogenetics?
With the recent influx of substantial expansion capital, Biogenetics is poised for significant operational scaling and market penetration. The company's strategic focus will likely involve enhancing its cryopreservation technologies, expanding its donor network, and broadening its global reach for reproductive cell and tissue distribution. Further investment may also be directed towards augmenting its urology and male fertility diagnostic services, solidifying its position as a leader in the fertility and cryobanking sector. This financing round signals strong investor confidence in Biogenetics' business model and its potential for future growth in the burgeoning fertility services market.
See full Biogenetics company page
